Clinical Trial

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

Study acronym: CATCH
Recruiting
View on ClinicalTrials.gov →
Summary
Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.
Protocol Amendment History 2 changes
notable Enrollment increased: 205 -> 300 participants 2026-06-10
notable Primary completion pushed: 2024-07-01 -> 2026-12-31 2026-06-10
Trial Details
NCT Number NCT06164808
Lead Sponsor HelpWear Inc.
Conditions Cardiac Arrhythmia, Diagnostic/Monitoring Devices Related to Adverse Incidents, Atrial Fibrillation (AF)
Enrollment 300 participants
Start Date 2024-02-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09